Literature DB >> 9762973

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.

H Daldrup1, D M Shames, M Wendland, Y Okuhata, T M Link, W Rosenau, Y Lu, R C Brasch.   

Abstract

OBJECTIVE: The endothelial integrity of microvessels is disrupted in malignant tumors. Quantitative assays of tumor microvascular characteristics based on dynamic MR imaging were correlated with histopathologic grade in mammary soft-tissue tumors.
MATERIALS AND METHODS: A spectrum of tumors, benign through highly malignant, was induced in 33 female rats by administration of N-ethyl-N-nitrosourea, a potent carcinogen. Dynamic contrast-enhanced MR imaging was performed using a small-molecular contrast medium (gadopentetate, molecular weight = 0.5 kDa) and a macromolecular contrast medium (albumin-(Gd-DTPA)30, molecular weight = 92 kDa) at an interval of 1-2 days. Permeability surface area product (PS), as estimated by the corresponding endothelial transfer coefficient (K(PS)), and fractional plasma volume (fPV) were calculated for each tumor and each contrast agent using a two-compartment bidirectional kinetic model. MR imaging microvascular characteristics were correlated with histopathologic tumor grade.
RESULTS: Tumor permeability to macromolecular contrast medium, characterized by K(PS), showed a highly positive correlation with tumor grade (r2 = .76, p < 10(-10)). K(PS) values were zero for all benign and some low-grade carcinomas, greater than zero in all other carcinomas, and increased in magnitude with higher tumor grade. A considerably smaller but significantly positive correlation was found between fPV and tumor grade using macromolecular contrast medium (r2 = .25, p < .003). No correlation between K(PS) or fPV values and tumor grade was found using gadopentetate (r2 = .01, p > .95 and r2 = .03, p > .15, respectively).
CONCLUSION: Quantitative tumor microvascular permeability assays generated with macromolecular MR imaging contrast medium correlate closely with histologic tumor grade. No significant correlation is found using small-molecular gadopentetate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762973     DOI: 10.2214/ajr.171.4.9762973

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  63 in total

1.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement.

Authors:  V Ntziachristos; A G Yodh; M Schnall; B Chance
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Authors:  Bénédicte F Jordan; Matthew Runquist; Natarajan Raghunand; Amanda Baker; Ryan Williams; Lynn Kirkpatrick; Garth Powis; Robert J Gillies
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.

Authors:  Xia Li; Hakmook Kang; Lori R Arlinghaus; Richard G Abramson; A Bapsi Chakravarthy; Vandana G Abramson; Jaime Farley; Melinda Sanders; Thomas E Yankeelov
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

4.  Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas.

Authors:  A Preda; P A Wielopolski; T L M Ten Hagen; M van Vliet; J F Veenland; G Ambagtsheer; S T van Tiel; M W Vogel; A M M Eggermont; G P Krestin; C F van Dijke
Journal:  MAGMA       Date:  2004-10-10       Impact factor: 2.310

5.  Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.

Authors:  Mukund Seshadri; David A Bellnier; Richard T Cheney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

6.  A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Terry O Matsunaga; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2013-04-11       Impact factor: 2.546

7.  Rapid simultaneous acquisition of T1 and T2 mapping images using multishot double spin-echo EPI and automated variations of TR and TE (ms-DSEPI-T12).

Authors:  Xin Liu; Yi Feng; Zheng-Rong Lu; Glen Morrell; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2010-01       Impact factor: 4.044

8.  Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.

Authors:  Xueming Wu; Eun-Kee Jeong; Lyska Emerson; John Hoffman; Dennis L Parker; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

9.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

10.  Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.

Authors:  Stephanie L Barnes; Jennifer G Whisenant; Mary E Loveless; Gregory D Ayers; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2012-07-27       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.